A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2001
12/13/2001	CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001	CA2411139A1 Inhibitors of c-reactive protein induced inflammation
12/13/2001	CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors
12/13/2001	CA2410577A1 Method for treating respiratory disorders associated with pulmonary elastic fiber injury
12/13/2001	CA2410509A1 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001	CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
12/13/2001	CA2409392A1 Intracellular signaling proteins
12/13/2001	CA2409342A1 Extracellular messengers
12/13/2001	CA2409015A1 Caspase inhibitors and uses thereof
12/13/2001	CA2408670A1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
12/13/2001	CA2408611A1 Kits and methods for optimizing the efficacy of chondroprotective compositions
12/13/2001	CA2408610A1 Low carbohydrate compositions, kits thereof, and methods of use
12/13/2001	CA2408609A1 Compositions, kits, and methods for promoting defined health benefits
12/12/2001	EP1161954A1 Treatment of T cell mediated autoimmune disorders
12/12/2001	EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases
12/12/2001	EP1161447A1 50 human secreted proteins
12/12/2001	EP1161442A2 Exocytosis pathway proteins and methods of use
12/12/2001	EP1161440A1 Method for refolding molecules of polypeptides containing ig domains
12/12/2001	EP1161434A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
12/12/2001	EP1161433A1 Tyrosine kinase inhibitors
12/12/2001	EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001	EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001	EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161280A1 Use of an integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia
12/12/2001	EP1161264A1 Polymer compositions for polynucleotide delivery
12/12/2001	EP1161261A1 Apoptosis inducing molecule ii and methods of use
12/12/2001	EP1161260A1 Tumor necrosis factor antagonists for the treatment of neurological disorders
12/12/2001	EP1161257A2 Pharmaceutical compositions comprising tgf-beta
12/12/2001	EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/12/2001	EP1161237A1 Protease inhibitors
12/12/2001	EP1161235A1 Combinations for the treatment of diseases involving angiogenesis
12/12/2001	EP1161234A2 Method for delivering benzidine prostaglandins by inhalation
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP1161150A1 Therapeutic antimicrobial compositions
12/12/2001	EP0971708B1 Nimesulide gel systems for topical use
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0869941B1 Modified polyunsaturated fatty acids
12/12/2001	EP0772597B1 3,4-substituted pyrazoles for the treatment of inflammation
12/12/2001	EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/12/2001	CN1326458A CRF receptor antagonists and methods relating thereto
12/12/2001	CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors
12/12/2001	CN1326455A Improved chemical process and pharmaceutical formulation
12/12/2001	CN1326443A Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
12/12/2001	CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III
12/12/2001	CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells
12/12/2001	CN1326356A Method of treating viral hemorrhagic fever
12/12/2001	CN1325718A Freeze dried compound queen bee powder
12/12/2001	CN1325691A Antagesic Chinese medicine and its preparing process and usage
12/11/2001	US6329526 Cycloalkyl substituted imidazoles
12/11/2001	US6329517 Dermatomyositis-specific auto-antigen
12/11/2001	US6329511 Humanized mouse af2 immunoglobulin having specific amino acid sequences; treatment of autoimmune diseases
12/11/2001	US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001	US6329418 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
12/11/2001	US6329415 Aromatic heterocyclic compounds as antiinflammatory agents
12/11/2001	US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001	US6329392 Substituted piperidines useful for the treatment of allergic diseases
12/11/2001	US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001	US6329380 Pyrimidine benzimidizazole, pyrimidineimidazole or pyridine imidazole compounds for anticancer agents or atherosclerosis
12/11/2001	US6329373 Metalloproteinase inhibitors
12/11/2001	US6329372 Phenylalanine derivatives
12/11/2001	US6329370 Cardiovascular disorders and tumor necrosis factor (hereinafter tnf.sub..alpha.), a cytokine with pro-inflammatory activity
12/11/2001	US6329365 Inhibitors of interleukin-1β converting enzyme
12/11/2001	US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
12/11/2001	US6329344 Urea derivative of alkylene dioxyfuran ethers
12/11/2001	US6329340 Human Defensin DEF-X
12/11/2001	US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues
12/11/2001	US6328997 Magnesium bicarbonate
12/11/2001	US6328964 Method to treat multiple sclerosis with GP39-specific antibodies
12/11/2001	US6328708 Device for controlled anaesthesia, analgesia and /or sedation
12/11/2001	CA2329482C Recombinant antibodies specific for tnf-.alpha.
12/11/2001	CA2226292C Substituted benzolactam compounds as substance p antagonists
12/11/2001	CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
12/11/2001	CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same
12/08/2001	CA2349776A1 Novel crystalline forms of (3s-trans)-2-¬3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2h-1-benzopyran-7-yl\|-4-(trifluoromethyl)-benzoic acid
12/06/2001	WO2001092892A2 Methods to identify compounds that modulate rage
12/06/2001	WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription
12/06/2001	WO2001092527A2 Regulators of apoptosis
12/06/2001	WO2001092496A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/06/2001	WO2001092492A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/06/2001	WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis
12/06/2001	WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
12/06/2001	WO2001092304A2 Transporters and ion channels
12/06/2001	WO2001092262A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/06/2001	WO2001092256A1 2,7-naphthyridine derivatives
12/06/2001	WO2001092253A2 Inhibitors of alpha l beta 2 mediated cell adhesion
12/06/2001	WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/06/2001	WO2001092238A1 Amorphous oxazole coumpound and its use as cox-2 inhibitor
12/06/2001	WO2001092233A1 3-substituted isoquinolin-1-yl derivatives
12/06/2001	WO2001092230A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
12/06/2001	WO2001092229A1 TNF-α PRODUCTION INHIBITORS
12/06/2001	WO2001092227A1 Chemical compounds
12/06/2001	WO2001092224A1 Indole derivatives with vascular damaging activity
12/06/2001	WO2001092221A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
12/06/2001	WO2001092220A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
12/06/2001	WO2001092210A1 Compounds for modulating the rage receptor
12/06/2001	WO2001092202A1 Il-8 receptor antagonists
12/06/2001	WO2001091793A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
12/06/2001	WO2001091792A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
12/06/2001	WO2001091780A1 Neuroprotective peptides

1 ... 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 ... 1272